Lecture 5 and 7 (Study Types) Flashcards

1
Q

Cohort study definition:

A
  • prospective, observational.
  • start with no diseases, look at exposure and disease development over time.
  • more expensive than case-control.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Statistic utilized for cohort study:

A

RELATIVE RISK

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Cross-sectional study definition:

A
  • single time point, observational.
    • take a slice of the population
  • how many people have a disease or a risk factor right now
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Statistic for cross-sectional study:

A

POINT PREVALENCE

point prevalence = (total #sick)/(total population)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Case-control study definition:

A
  • retrospective, observational.
  • start with disease and go back retrospectively to find the risk factor
  • cheaper than cohort studies
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Statistic for case-control study:

A

ODDS RATIO

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Nested case-control study definition:

A
  • select cases and controls from a cohort study
  • go back and find the risk factor
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

The three types of error in studies:

A
  1. random (chance)
  2. systematic (bias)
  3. confounders
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Random error:

A
  • chance
  • will cancel out as sample gets larger
  • more likely will lead to type 2 error
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Systematic error (bias):

A
  • cannot be corrected for regardless of sample size
  • more likely will lead to a type 1 error
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Confounder definition:

A
  • must be associated with exposure
  • must be associated with outcome
  • cannot be in the causal pathway between exposure and outcome
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

How can you control for confounding?

A
  • At the design stage:
    • randomization
    • restriction
    • matching
  • At the analysis stage:
    • stratification
    • multivariable adjustment (regression)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Selection bias:

A
  • nonrandom assignment to groups
  • loss to follow up
  • must be controlled at design stage.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Healthy worker effect (bias):

A
  • workers are generally healthier than the general population.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Self-selection bias:

A
  • research volunteers different from the general population in terms of their exposure and disease status.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Withdrawal bias:

A
  • differential loss to follow-up; people drop out
  • drop outs may be more sick
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Recall bias:

A
  • knowledge of presence of disease changes subject’s response
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Sampling bias:

A
  • subjects are not representative of population, non-generalizable
19
Q

Confounding bias:

A
  • one factor distorts/confuses the effect of another closely related one.
20
Q

Information/observer bias:

A
  • researcher’s decision affected by prior knowledge of subject’s exposure.
  • Correct for by blinding.
  • must be controlled at design stage
21
Q

What forms of bias are case-control studies sensitive to?

A
  • recall bias
  • selection bias
  • observer bias
22
Q

Case-control study benefits:

A
  • good for rare diseases
  • can test for a wide variety of exposures
  • important in understanding new diseases
  • commonly used in outbreak investigations
23
Q

Cohort study benefits:

A
  • can choose all the variables you want
  • can control for bias and confounders
24
Q

How to choose sample for case-control study:

A
  • Case definition should not be too broad - misclassifies
  • Case definition should not be too narrow - reduces sample size
  • Cases and controls should be members of the same base population and have had equal opportunity to have been exposed (same environment).
25
Proces of the development and testing of a new clinical test (index test):
need to compare index test to reference test: 1. select patients 2. test all patients with index test 3. test and diagnose all patients with reference test 4. compare index test results with reference test results
26
Potential bias in an index test study:
1. utilization of wrong reference test 2. spectrum bias 3. verification bias 4. observer bias
27
Spectrum bias:
* applies to index test studies * patients in study not the same as those found in standard practice * i.e. using only patients more likely to test positive - will make test look better
28
Verification bias:
* applies to index test studies * not all patients in study receive both the index and reference test
29
Analytical observational studies:
* Observe events as they happen in the ‘real world’ without playing an active role in what happens. * "Incidence" studies * Two-types: 1. cohort 2. case-control
30
What is a cohort?
* a group of people with something in common who are then followed over time to see what happens to them. * should not have the outcome at enrollment, but should be at risk for it
31
Effect modifiers are:
* Effect modifiers are variables that change the effect of the exposure of interest on risk of disease. * "interaction"
32
Randomization:
* an attempt to evenly distribute potential (unknown) confounders in study groups.
33
Restriction:
* excludes participants with known confounding variables * may decrease sample size and power
34
Stratification:
* stratify data by a potential confounder, and then compare both groups
35
Matching:
* For each subject in the exposed group, one or more patients with the same characteristic (with or without the confounder, eg. smoker or nonsmoker) is chosen for the non-exposed group. * has to be coupled with a matched analysis
36
Randomized control trial:
* prospective, interventional, gold standard * treatment versus placebo — watch outcome * statistics: NNT/NNH; multiple comparisons * four phases
37
Meta-analysis study:
* retrospective, chart review, platinum standard * pools data from multiple studies, usually RCTs * analyzes cumulative data to determine external validity
38
Twin concordance study:
**genes versus environment (early life)** * monozygotic = identical twin, same genetic material, same environment * dyzygotic = non-identical twins, different genetic material, same environment
39
Adoption study:
**genes versus environment (later life)** * come from genetically sick family, raised in completely different environment, but still get sick. Hints to powerful effect of genes.
40
RCT Phase 1:
**_SAFETY_** * small # healthy volunteers * toxicity * pharmacokinetics * in cancer, phase I studies will include critically ill/terminally ill patients
41
RCT Phase 2:
**_EFFICACY_** * small # patients with disease * dosing * adverse reactions
42
RCT Phase 3:
**_TREATMENT VERSUS CONTROL_** * large # patients with disease * compares standard treatment to novel treatment
43
RCT Phase 4:
**_post-marketing SURVEILLANCE_** * after drug has been approved * watches for rare, long term effects